GoodRx Holdings (GDRX) Return on Capital Employed (2020 - 2026)

GoodRx Holdings (GDRX) has 7 years of Return on Capital Employed data on file, last reported at 9.15% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed rose 254.0% year-over-year to 9.15%; the trailing twelve-month figure through Mar 2026 stood at 9.15% (up 254.0% YoY), and the FY2025 full-year result was 7.61%, up 278.0% from the prior year.
• Return on Capital Employed rose to 9.15% in Q1 2026, from 7.82% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 9.15% in Q1 2026 to a low of 2.2% in Q1 2024.
• A 5-year average of 2.69% and a median of 2.26% in 2024 frame the typical range for Return on Capital Employed.
• Across the five-year window, Return on Capital Employed jumped 2702 bps in 2022 and plunged 315 bps in 2024, its largest moves.
• Tracing GDRX's Return on Capital Employed over 5 years: stood at 0.12% in 2022, then tumbled by 1637 bps to 1.77% in 2023, then surged by 398 bps to 5.28% in 2024, then jumped by 48 bps to 7.82% in 2025, then advanced by 17 bps to 9.15% in 2026.
• Business Quant data shows GDRX's Return on Capital Employed at 9.15% in Q1 2026, 7.82% in Q4 2025, and 7.28% in Q3 2025.